However, recent guidelines recommend IGF-1 level measurement to alsoinclude those without typical manifestations but with several atypical signs suchas sleep apnea, type 2 diabetes mellitus, debilitating arthritis, carpal tunnelsyndrome, and hypertension [8]. This evidence concerns the gene IGF1 and diabetes mellitus.